views

This Respected Outfit Supplying Loads of Drugs could Have a Healthy Future

Hello Share Takers. Medical companies are still high on my list of sectors that could outperform the market this year. A company I’ve not considered before but which has a healthy record is Hikma Pharmaceuticals (HIK).

views

We Have a Moral Duty to Invest in Medical Science. And Here's Another Suggestion for you.

Hello Share Bashers. This old punter watched a hero of his on tv the other night. Jeremy Paxman has Parkinson’s disease and he was explaining how he coped with this lousy throw of the dice and how it’s being treated. Like quite a few horrible conditions, the number of Parkinson patients is growing. So too are drugs which are holding back illness. That’s why I think we and all investors should have some pharmaceuticals in our portfolios.

NEWSFLOW

Hikma Pharmaceuticals (#HIK) – additional clinical endpoint study required for generic Advair Diskus

NEWSFLOW

Hikma Pharmaceutical (#HIK) - Resolution to FDA Warning Letter

views

Zak Mir's Bear Call Of The Day: Hikma Pharma: Pullback Towards 1,800p Expected

There was certainly a great bull run for shares of Jordan based pharma Hikma (HIK) ahead of its entry into the FTSE 100 in March, something it would appear that the tracker funds managed to anticipate to perfection.